Overview
For the last several years, Bionique Testing Laboratories has been in a unique position to facilitate the adoption of rapid mycoplasma testing strategies by their clients. Predominantly cell therapy developers motivated by particularly short production schedules and product shelf life, this pool of clients has grown to include raw material providers interested in reducing inventory hold times.
This discussion will cover lessons learned throughout Bionique’s experience with guiding sponsors through the process of developing and qualifying or validating a MycoSEQ-based rapid mycoplasma testing strategy.
In this webinar you will learn the importance of demonstrating product specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence.
Who could benefit?
Anyone considering the adoption of a rapid mycoplasma testing strategy including assay development scientists, QC managers, Global Product Quality leads, and other CMC focused quality professionals.
Presenters: Cynthia Martino, R&D Director, Bionique Testing Laboratories and Mike Auerbach, Editor-in-Chief, American Pharmaceutical Review.
Sponsored by: ThermoFisher Scientific
Would you like to learn more?
To obtain more information about our services
or to speak to a team expert contact us now.